Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • dawnandrew100
    Junior Member
    • Aug 2025
    • 3

    #1

    Introduction

    Hi everyone! I'm Andrew. I currently work as a Medical Laboratory Scientist/EMT but I'm also a PhD student studying bioinformatics and computational biology. I'm still relatively new to the field of bioinformatics but I appreciate all the knowledge I've gained so far. Over the past year, I've been able to start a few open source projects over on GitHub that I'm pretty proud of and I have lots of ambitions to do even more. One of my future projects will be a generalized PBPK/PBPD model that is a part of a simulation that can simulate the body's response to a drug as well as estimate the clearance time for the drug compared to a healthy digital twin simulation. The goal will be to take any arbitrary drug and disease state and run the simulation to get plausible results.

    I'm happy to be here and hope to meet other like-minded individuals!
  • seqadmin
    Senior Member
    • Oct 2022
    • 729

    #2
    Welcome to SEQanswers, Andrew! It’s great to have you here. Your background and projects sound really exciting. We're looking forward to seeing your contributions and discussions as you continue your work in bioinformatics.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 10:13 AM
    0 responses
    13 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    19 views
    0 reactions
    Last Post SEQadmin2  
    Working...